BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

Inveresk Research (Incorporating CTBR) (IRGI) Prices Common Stock Offering; 10,000,000 Shares Of Its Common Stock At A Price Of $20.00 Per Share


10/19/2005 5:10:49 PM

CARY, N.C., Nov. 20 /PRNewswire-FirstCall/ -- Inveresk Research Group, Inc. today priced a public offering of 10,000,000 shares of its common stock at a price of $20.00 per share. The offering is comprised of 9,000,000 shares being offered by various selling stockholders and 1,000,000 shares being offered by Inveresk. The underwriters for the offering are Bear, Stearns & Co. Inc., Goldman, Sachs & Co., William Blair & Company, L.L.C., SG Cowen Securities Corporation and Jefferies & Company, Inc. The underwriters have been granted a 30-day option to purchase up to an additional 1,500,000 shares from certain of the selling stockholders for the purpose of covering over-allotments.

This press release shall not constitute an offer to sell or the solicitation of an offer to buy nor shall there be any sale of these shares in any state in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state. Copies of the prospectus and prospectus supplement relating to these securities may be obtained by contacting Bear, Stearns & Co. Inc., 383 Madison Avenue, New York, NY 10179, telephone number 212-272-2000.

Inveresk is a leading provider of drug development services to companies in the pharmaceutical and biotechnology industries. The company is based in Cary, North Carolina with facilities in Edinburgh, Scotland and Montreal, Canada.

Inveresk Research Group, Inc.

CONTACT: Bear, Stearns & Co. Inc. +1-212-272-2000



Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES